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Abstract
Background
Most of the evidence on antimicrobial stewardship programmes (ASP) to help sustain the
effectiveness of antimicrobials is generated in high income countries. We report a study
investigating implementation of ASP in secondary care across low-, middle- and high-
income countries. The objective of this study was to map the key contextual, including cul-
tural, drivers of the development and implementation of ASP across different resource
settings.
Materials and methods
Healthcare professionals responsible for implementing ASP in hospitals in England, France,
Norway, India, and Burkina Faso were invited to participate in face-to face interviews. Field
notes from observations, documentary evidence, and interview transcripts were analysed
using grounded theory approach. The key emerging categories were analysed iteratively
using constant comparison, initial coding, going back the field for further data collection, and
focused coding. Theoretical sampling was applied until the categories were saturated.
Cross-validation and triangulation of the findings were achieved through the multiple data
sources.
Results
54 participants from 24 hospitals (England 9 participants/4 hospitals; Norway 13 partici-
pants/4 hospitals; France 9 participants/7 hospitals; India 13 participants/ 7 hospitals;
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Burkina Faso 8 participants/2 hospitals) were interviewed. Across Norway, France and
England there was consistency in ASP structures. In India and Burkina Faso there were
country level heterogeneity in ASP. State support for ASP was perceived as essential in
countries where it is lacking (India, Burkina Faso), and where it was present, it was per-
ceived as a barrier (England, France). Professional boundaries are one of the key cultural
determinants dictating involvement in initiatives with doctors recognised as leaders in ASP.
Nurse and pharmacist involvement was limited to England. The surgical specialty was iden-
tified as most difficult to engage with in each country. Despite challenges, one hospital in
India provided the best example of interdisciplinary ASP, championed through organisa-
tional leadership.
Conclusions
ASP initiatives in this study were restricted by professional boundaries and hierarchies, with
lack of engagement with the wider healthcare workforce. There needs to be promotion of
interdisciplinary team work including pharmacists and nurses, depending on the available
healthcare workforce in different countries, in ASP. The surgical pathway remains a hard to
reach, but critical target for ASP globally. There is a need to develop contextually driven
ASP targeting the surgical pathway in different resource settings.
Background
Research in tackling antimicrobial resistance (AMR) and implementing antimicrobial stew-
ardship is necessary from different cultures, economies and healthcare organisations. There
are increasing calls for identifying global solutions to the threat of AMR [1,2]. It is only when
we know what the challenges are across the spectrum of healthcare globally that we can start
finding contextually fit solutions. It is often argued that quality in healthcare should be univer-
sal, and it should be accountable to the same standards worldwide. Likewise, for antimicrobial
stewardship programmes (ASP), a shared agreement of its central principles is necessary for it
to be implementable across different countries and economies[3]. The first step to doing this is
to understand what the contextual and cultural determinants are in different countries and
how they can be addressed. Decision-making in healthcare is complex and contextually driven
with multiple actors and actions[4]. This complexity is evident in antibiotic decision-making
where different priorities and contextual factors influence behaviours[5–9]. The influence of
hierarchies and peer influence on antibiotic prescribing in hospitals[5,10], with the need for
tailoring interventions to the context in which they are to be implemented and ensure local
ownership[11]. Countries however are at different stages of implementing ASP[12–14], yet,
most research and evidence for ASP continues to be from high income countries[15–17]. The
latest Cochrane systematic review of interventions to improve antimicrobial prescribing,
included 221 studies[17] of which, 183 (83%) were from Europe and North America. One of
the findings of the Cochrane review was that few interventions include behavior change or
behavior theory, and globally reported variation in antibiotic prescribing cannot be resolved
without an appreciation and understanding of the social influences in antibiotic decision-mak-
ing[18]. There remains a gap in the evidence base on the effective means of 1) influencing anti-
biotic prescribing behaviours and; 2) effective and sustainable assimilation of stewardship
interventions into existing healthcare frameworks. There is now a growing interest in low- and
Cultural and contextual determinants of antimicrobial stewardship programmes in different health economies
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middle-income countries (LMIC) to implement programmes to control and optimise antimi-
crobial use[13,14,19,20]. These efforts are also supported by international reports highlighting
the urgent need to tackle AMR on a global scale[21,22].
ASP interventions are designed, implemented and expected to be adopted with little insight
on the culture and context in which they are to function sustainably. Culture is defined as the
knowledge that people use to develop shared beliefs, practices and norms that distinguish one
group of people from another, e.g., the culture across different specialties, organisations or
countries can influence and shape behaviours and intervention outcomes[23]. We report on
the findings of a study, which was conducted at the macro and meso level, investigating the
development and implementation of ASP in different healthcare settings across five countries
(England, Norway, France, India, and Burkina Faso). The countries in this study were conve-
niently selected to represent different healthcare systems and cultures, different resources
and facing very different challenges in terms of healthcare associated infections (HCAI). Con-
ducting this study across these different countries provided a unique opportunity to map the
implementation process of ASP to generate evidence base for the most effective means of
implementing sustainable and successful interventions in healthcare organisations. It is impor-
tant to conduct this study across different economies, at different stages of implementation of
stewardship to enable bi-directional learning. Norway, France, and England represent high-
income countries in this study as defined by the Organisation for Economic Co-operation and
Development, India is classified as a lower middle-income country, and Bukina Faso is classi-
fied as a least developed country[24]. This study was conducted at cross-professional, cross-
specialty and cross-national level to help identify the challenges facing healthcare systems in
the implementation of ASP, and the cultural determinants that shape and drive interventions.
The objective of this study was to map the key contextual, including cultural, drivers of the
development and implementation of ASP across different resource settings. The countries in
this study were conveniently selected to represent different healthcare cultures, different
resources and facing very different challenges in terms of HCAI. Conducting this study across
these different countries provided a unique opportunity to map the implementation process of
ASP to generate evidence base for the most effective means of implementing sustainable and
successful interventions in healthcare organisations.
Methods
Overview of the healthcare systems in each country
Prior to selecting the countries in this study, a search of the grey literature was conducted to
assess the state of the healthcare system in each of the countries. This search was undertaken to
identify the existing stewardship programmes in each country, together with the key indicators
in relation to antimicrobial resistance and ASP. This data helped provide contextual back-
ground knowledge for each country and helped the analysis of the qualitative data by provid-
ing background detail. We used the Centre for Disease Control (CDC) components for
stewardship to assess the existing ASP activities in each country[25]. The CDC components
were used because they have longest established record of producing standards for ASP and
are the most widely recognised worldwide.
Face-to-face interviews
The study interview guide was piloted in England and in India (via telephone interviews before
commencing the study). Data collection from the field was carried out in Norway (May 2015),
France (December 2016), England (March 2017), Burkina Faso (June 2017), and India (April
2017). The duration of data collection in each country was two weeks. The key collaborators in
Cultural and contextual determinants of antimicrobial stewardship programmes in different health economies
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each country were invited to participate in this study because of their existing work in ASP.
Through snowballing and purposive sampling, the key collaborators in each country nomi-
nated healthcare professionals with roles in ASP. Individuals showing an interest were
contacted by the collaborators and a mutually convenient time arranged for face-to-face inter-
views. Informed consent from participants was obtained prior to each interview. The key
themes emerging during the interviews were investigated in more depth through further ques-
tioning during the interviews. Methodological triangulation was achieved through respondent
validation and reflexivity. Data triangulation was achieved through collecting the data over dif-
ferent periods of time, from different persons, across different hospitals, teams, and specialties.
This approach of combining data from different sources, and persons helped increase the
validity and reliability of the data collected, and reduced observer bias.
In Burkina Faso, AP conducted the interviews in the local language (French). The interview
guide had been translated to French (English and French interview guides available as support-
ing materials S1 and S2). All interviews were audio recorded and sent to be transcribed verba-
tim by a transcription company. The transcripts from Burkina Faso were translated to English
by AP. The interviews in the other countries were conducted by EC, in English.
Ethics approval and consent to participate
Ethical approval to conduct this study was gained from all the participating countries by the
country collaborators (Burkina Faso AP and XFL, England EC, France J-CL, India SS, Norway
IS). The following ethical committees granted approval for this study: Comite´ d’Ethique de
Recherche en Sante´ (CERS) du Burkina Faso (Burkina Faso); Imperial College Joint Research
Office Ethical Board (England); Amrita Institute of Medical Sciences Ethics Committee in
Ponekarra (PO), Kochi (India); Comite´ d’Evaluation de l’Ethique des projets de Recherche
Biome´dicale (CEERB) (France); The Data Protection Officer at Haukeland University Hospi-
tal, representing the Norwegian Data Protection Authority (Norway). Prior to interviews, ver-
bal and written informed consent was obtained from all participants. The participants were
emailed the study information sheet prior to the interview. On the day of the interview the
interviewer verbally described the study to the participants. An informed consent sheet was
signed by the participant prior to starting the interview.
Data analysis
Familiarisation with the data began by conducting the interviews (EC, AP), listening to the
recordings of the interviews and reading the transcripts (EC, Anne P, IS, BS). Nvivo 11 soft-
ware (QSR International) was used for analysis of all the qualitative data from field note obser-
vations and the transcripts.
The analysis and data collection were simultaneous using established methods of grounded
theory [26–28]. Analysis was through an iterative process and constant comparison using ini-
tial coding, going back the field for further data collection, and focused coding. The key emerg-
ing categories and ideas were analysed using constant comparison, and theoretical sampling
was applied until the categories were saturated. The initial analysis was performed by EC. Co-
authors IS, BS, Anne P, SS, and AH provided contextual and interpretive insights into the tran-
scripts and the emerging data from each country. They each read the transcripts from their
respective countries and provided analytic input into the data gathering and theoretical sam-
pling. The cultural categories and relationships within the recognised categories were explored
to develop the theoretical statements. The constant comparative method was also used for the
analysis of the emerging themes[29]. This iterative and recursive process of moving between
the coded data and the higher-level categories and themes, was repeated until the themes, and
Cultural and contextual determinants of antimicrobial stewardship programmes in different health economies
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the relationship between the themes, reached saturation (i.e. now new themes or inter-rela-
tionships between them were identified).
Results
Overview of health systems of the countries included in this study
The healthcare infrastructures in India and Burkina Faso are inadequate for the needs of the
population, as represented by the number of hospital beds per 1000 (Fig 1). These countries
also face the greatest burden of AMR, as exemplified by the reported aminoglycoside resistance
rates to urine Escherichia coli isolates in inpatients (Fig 1). In Norway, France, and England
this study found there to be country-level consistency in the provision of healthcare and
the structures in place for ASP. In four of the countries, healthcare is technically free to all citi-
zens at the point of care (Table 1). The issue of excess versus access to antimicrobials was
highlighted in a recent study reporting increase in global antimicrobial consumption rates
[30]. Access to antimicrobials is more challenging in countries with the highest burden of
infectious diseases. The challenges of access to antimicrobials was also a finding in the qualita-
tive study we report here. In Burkina Faso and India where there is no regulation imposed on
the access to antimicrobials, patients and the public can also obtain them through informal
routes.
This study found country level (Norway) or hospital level (England, France) antimicrobial
prescribing guidelines (Table 2). The leadership commitment and appointing a single person
responsible for ASP is present in England, France and Norway (Table 2). This also ensures
clear lines of accountability for antimicrobial optimisation and use. In these countries there
are processes in place to track the hospital level antimicrobial use and resistance patterns. In
addition, these countries have implemented some form of regular reporting of antimicrobial
use and resistance to healthcare professionals in hospitals.
Across the five countries, 61 individuals from 33 hospitals were invited to participate in the
study. Nine individuals (India 2, Norway 2, France 2, England 3), refused to participate or did
not respond to the two emails that were sent. In total 52 participants from 24 hospitals were
Fig 1. The reported % aminoglycoside resistance in Escherichia coli urine isolates in inpatients[1,31] against the investment in
healthcare and public hospital beds per 1000 (source: The World Bank http://data.worldbank.org/indicator/SH.MED.BEDS.
ZS), represented by bubble size.
https://doi.org/10.1371/journal.pone.0209847.g001
Cultural and contextual determinants of antimicrobial stewardship programmes in different health economies
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interviewed (Table 3). The male to female ratio of participants was 2 (35 male and 17 female).
The years in practice in the stated profession of the participants ranged from 5–42 years.
The key emerging themes
Analysis of the interviews, and the observational data identified key insights into the determi-
nants of ASP in these different settings. These insights are summarised in Table 4 and are
described in detail in the sections below.
Table 1. Population level data for the countries in this study.
Country data Norway France England India Burkina Faso
Official Development Assistance ranking High Income High Income High Income Lower Middle Income Least Developed
Population 5.2 Million 66 Million 53 Million 1.3 Billion 18.6 Million
Doctors per 1000 population (WHO) 4.42 3.2 2.8 0.75 0.05
Antimicrobial consumption DDD/1000
inhabitants per day [30]
15.4 35.4 23.2 13.5 5.8 (Figure for French
West Africa, which
includes Burkina Faso)
The estimated burden of HCAI as % hospital
admissions [32,33] (India and Burkina Faso
prevalence calculated by EC based on
published papers [31,34–39]
5.1 6.7 7.6 25 23
Healthcare provision Universal public
care
Federal
Administration
Universal
healthcare
Central
Administration
Universal
healthcare
Central
Administration
Universal healthcare, access
forces people into private care,
Federal Administration
Universal healthcare being
developed
Central Administration
Hospital accreditation Mandated by law Mandated by law Mandated by law Voluntary Voluntary
Access to antimicrobials Only via
prescription
Only via
prescription
Only via
prescription
No regulation easy access to
black market medications
No regulation easy access
to black market
medications
The countries included in the study are all responding to the WHO National Action Plans for AMR, primarily via government-initiated activities. Burkina Faso is the
only country which is yet to develop a National Action Plan, and currently there are no national initiatives or guidelines. Local ASP policies are based on the French
system which is not fit for purpose in the context of healthcare in Burkina Faso.
https://doi.org/10.1371/journal.pone.0209847.t001
Table 2. Key stewardship activities present across the hospitals in this study by country (�In India, one hospital in this study exhibited positive deviance).
The 2014 CDC Key components of stewardship Norway France India� England Burkina
Faso
Providing antimicrobial prescribing guidelines
p
national
p
local and
national
p
state-wide–not
implementable
p
local and
national
p
local
Leadership Commitment: Dedicating necessary human, financial and information
technology resources.
p p p
Accountability: Appointing a single leader responsible for program outcomes.
Experience with successful programs show that a physician leader is effective.
p p p
Drug (Pharmacist) Expertise: Appointing a single pharmacist leader responsible for
working to improve antimicrobial use.
p
Action: Implementing at least one recommended action, such as systemic evaluation of
ongoing treatment need after a set period of initial treatment (i.e. “antimicrobial time
out” after 48 hours).
p p
Tracking: Monitoring antimicrobial prescribing and resistance patterns.
p p p
Reporting: Regular reporting information on antimicrobial use and resistance to
doctors, nurses and relevant staff.
p p p
Education: Educating clinicians about resistance and optimal prescribing.
p p p
state level
p p
limited
https://doi.org/10.1371/journal.pone.0209847.t002
Cultural and contextual determinants of antimicrobial stewardship programmes in different health economies
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Table 3. Study participant data.
Country Organisation type (study site number) No of beds Participant Profession
Norway �University Hospital A 1100 Pharmacist
Doctor
Doctor
Doctor
Doctor
Doctor
Doctor
Doctor
Regional Hospital B 81 Pharmacist
University Hospital C 947 Doctor
Doctor
Private Hospital D 184 Doctor
Doctor
France �University Hospital E 987 Doctor
Doctor
Doctor
Regional University Hospital F 1500 Doctor
Regional Hospital G 735 Doctor
Hospital H 475 Doctor
General Hospital I 800 Doctor
University Hospital J 300 Doctor
University Hospital K 1000 Doctor
India Government University Hospital L 1250 Doctor
Missionary (Private Charitable) Hospital M 1800 Doctor
�Private Charitable University Hospital N 1350 Surgeon
Pharmacist
Pharmacist
Doctor
Doctor
Surgeon
Private Hospital O 420 (Full operational capacity 1100) Doctor
Government District Hospital P 750 Doctor
Government University Hospital Q 600 Doctor
Doctor
Government University Hospital R 500 Doctor
England �University Hospital S 890 Doctor
Pharmacist
Pharmacist
University Hospital T 450 Doctor
Doctor
University Hospital U 1000 Doctor
Pharmacist
University Hospital V 1100 Pharmacist
Nurse
(Continued)
Cultural and contextual determinants of antimicrobial stewardship programmes in different health economies
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Government and state infrastructure as determinants of ASP. In India and Burkina
Faso, there is great disparity in the level of access to healthcare, and the quality of healthcare
provided. There is variation in the availability and type ASP models in secondary care. Bureau-
cracy and inefficient systems force individuals to seek private healthcare. Government
Table 3. (Continued)
Country Organisation type (study site number) No of beds Participant Profession
Burkina Faso University Hospital W 600 Pharmacist, PHD
Pharmacist
Doctor
Doctor
University Hospital X 800 Doctor
Doctor
Pharmacist
Pharmacist
�Denotes the reference study site in each country.
https://doi.org/10.1371/journal.pone.0209847.t003
Table 4. Key emerging themes from the data.
Emerging theme Theme explanation Examples Implications
Government and state
infrastructure are perceived as
determinants of ASP
Government or state support and
endorsement of ASP initiatives is a key
determinant in implementation and
adoption of ASP, however depending on
the degree and level of involvement it can
be perceived both as a facilitator and a
barrier to effective ASP.
Government or state involvement in ASP
is present in England through the
Department of Health guidelines and
hospital inspections. These government
initiatives can be considered too invasive
and disruptive to ASP. In India and
Burkina Faso, there are no state
involvement in ASP, and this is perceived
by the participants in this study to be the
reason for no impetus to implement any
ASP in hospitals.
Infrastructure to support ASP through
legislation of access to antimicrobials and
accreditation of hospitals is present in
England, France and Norway, but absent
from India and Burkina Faso.
In England, too much government
interference in ASP through conflicting
messages creates disruptions to the
healthcare system in relation to ASP.
Lack of infrastructure to legislate and
control access to antimicrobials is a major
gap in India and Burkina Faso and needs
to be addressed for the widespread
adoption of ASP. However, local
championing and leadership can still
result in successful ASP in the absence of
central government endorsement.
Professional boundaries dictate
involvement in ASP
Implicit and explicit professional
boundaries determine the roles that
healthcare professionals can adopt in ASP.
Entrenched hierarchies within
organisations and between the professions
define the boundaries of power and
influence in ASP.
It is an accepted maxim that doctors are
the decision makers in hospitals in
Norway, France, Burkina Faso and India.
These are implicit (through widely held
beliefs and cultural norms), and explicit
(through legislation and job descriptions
and definitions). These boundaries
determine what role individuals from
different professions can have in ASP.
England in this study remained the only
example of country-wide acceptance and
involvement of nurses and pharmacists in
ASP. The examples from England and one
key site in India exhibiting positive
deviance, demonstrate that these
healthcare professionals can have an
essential role in ASP. Furthermore, the
example from India, supports the theory
that with local champions these healthcare
professions can overcome the professional
boundaries and national/organisational
hierarchies and establish a role for
themselves in ASP.
Social norms and values in
relation to antimicrobial
decision making are different
in medicine versus surgery
Surgical and medical specialties are
reported to exhibit different social norms,
values and behaviours in relation to ASP
Across all the countries in this study the
surgical specialty was identified as being
more difficult to involve in ASP, and
surgical teams’ antimicrobial prescribing
was considered to need more attention as
part of ASP.
Historically ASP have targeted medical
specialties. Antimicrobial prescribing
across the surgical pathway needs to be
addressed as part of ASP.
https://doi.org/10.1371/journal.pone.0209847.t004
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hospitals often have limited budgets for patient services. The diagnostic capability of the
microbiology laboratories of the government hospitals is often technologically 10–15 years
behind. In addition, due to the relaxed regulations and no mandatory accreditation for hospi-
tals there are a variety of hospitals and healthcare providers which serve the population at
different costs. Often, by the time patients are hospitalised they have already taken several dif-
ferent over the counter antimicrobials (ranging from a single tablet to a full course), and the
lack of access to or availability of medical records makes it impossible to know the full past
medical history (including infections or antimicrobial exposure) for individual patients,
Table 5 (T1Q1, T1Q2). The pharmaceutical companies can provide barriers to effective ASP
through the influence of their representatives on the prescribing behaviours of doctors
(Table 5, T1Q3) and through the production of substandard antimicrobials (Table 5, T1Q4).
Furthermore, there is the risk of black market drugs infiltrating the secondary care supply
chain.
‘The regulation is very poor. Companies making generic antimicrobials make two formula-
tions, one for export, one for use in India, in one study on cephalosporins, the Indian generic
version had 15% less potency. We had a case of aspergillosis. The drug of choice is voricona-
zole. In the Indian market, there are voriconazole from 200 rupees to 2,000 rupees. We gave
the patient the option. He chose the cheapest one, the Indian generic one. We gave the correct
dose of voriconazole, the infection did not respond. Then we did the therapeutic drug monitor-
ing, we found that the concentration was at least five to six time less than the original drug . . .
so we had to give five to six times the dose of the generic drug.’ Medical Microbiologist, India
Hospital N
In the UK, resource is limited in a different way. The National Health Service (NHS) is
under pressure to save money year on year, both in staff resourcing and in consumables such
as drug expenditures. At the same time the healthcare system is subject to regular disruptions
in the form of restructuring of the workforce and management teams. During this study, NHS
England launched the Commissioning for Quality and Innovation (CQUIN) initiative for
reducing the burden of AMR and sepsis[40]. In secondary care CQUIN provides financial
incentives to hospitals for gathering and sharing data on antimicrobial consumption and
review, and a further incentive for demonstrating reduction in antimicrobial use for specific
agents. The participants from English hospitals included in this study had mixed responses to
the impact of the CQUIN. Some considered it as an opportunity to get the rest of the organisa-
tion to focus on ASP (Table 5, T1Q5). Others, though they had participated in the initiative
perceived it to be more disruptive and lacking insight into the practicalities of ASP (Table 5,
T1Q6 –Q7).
The English experience is at odds with the India and Burkina Faso experience. In these
countries, central government involvement is lacking but is attributed a high value by health-
care professionals, whereas in the UK it is attributed a low value by healthcare professionals,
though it is an active driver of ASP. In India and Burkina Faso healthcare professionals con-
sider ASP to be the responsibility of central government. Unless driven by central government
and mandated by law, ASP initiatives will not take root in hospitals (Table 5, T1 Q8 –T1 Q9).
In France and Norway central government led health indicators are driving the need to
develop some level of ASP in hospitals. In Norway, a country beginning to initiate ASP, gov-
ernment input is perceived as a facilitator to bring about change in ASP (Table 5, T1 Q10).
Limited resources at hospital level can hinder the implementation of ASP. In smaller rural hos-
pitals lack of recruitment of staff and access to expertise pose obstacles to the implementation
of ASP (Table 5, T1Q11 –Q12).
Cultural and contextual determinants of antimicrobial stewardship programmes in different health economies
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Professional boundaries decide involvement in ASP. In many parts of the world, includ-
ing France, Norway and India ASP is still predominantly led by doctors (including infectious
disease doctors or medical microbiologists). The role of the wider healthcare workforce in ASP
is undefined and limited. France has a long history of ASP in its secondary healthcare. Tradi-
tionally the treatment of infections has been the remit of intensive care physicians and the
intensive care units still play a pivotal role in ASP, and in infection management of patients
(Table 5, T2 Q13). This has led to barriers to the ASP team to be accepted as a valid source of
advice in the ICU setting, and the doctors working in ASP teams can be held at arm’s length
by clinicians and regarded as a ‘we will call you if we need you’ service rather than a more col-
laborative service. This type of professional boundaries still abounds in the clinical setting and
delineates who can do what. In the countries in this study, bar England and Burkina Faso,
pharmacists do not traditionally have an active role in ASP. Traditional professional hierar-
chies remain entrenched in healthcare systems, leaving the nurses and pharmacists with little
expectation to be part of the antimicrobial decision making (Table 5, T2Q14 –Q16). Within
the medical profession there remain also concerns of stepping into another specialty’s terri-
tory. The ASP teams report an acute awareness of the sensitivity of dispensing advice to other
clinicians about the care of their patients (Table 5, T2 Q17 –Q19). To be accepted by the other
clinical professions, the participants from Indian hospitals expressed a greater need for support
from the hierarchy in the organization (Table 5, Q20). Despite the country level propensity for
ASP to be exclusive to doctors, the key study sites in each country exhibited similarities in the
level of openness and inclusion in ASP with emphasis on and appreciation of interdisciplinary
collaboration (Table 5, T2Q21).
Social norms and values in relation to antimicrobial decision making are determined at
specialty level. The study participants reported an awareness of the different practices in
relation to antimicrobial prescribing amongst different specialties. One finding across the
countries was the challenges facing ASP teams in engaging with and optimising antimicrobial
use across surgical teams. Generally, it was reported that surgical specialties are the least likely
to adhere to antimicrobial prescribing guidelines, whereas ICU teams being protocol driven
and used to multidisciplinary input are the most likely to adhere to them (Table 5, Q22 –Q23).
France and India both present the more hierarchical cultures[41] and this was reflected in
the findings with the surgeons reported as being on top of the hierarchy in hospitals. The sur-
geons’ position in the hierarchy manifests itself as a reluctance to follow general expectations
of behaviour in relation to infection management and antimicrobial prescribing. Due to the
lack of attention to the medical care of the surgical patients and ineffective co-management,
the medical needs of surgical patients can be neglected and overlooked (Table 5, Q24 –Q25).
The reasons for these reported differences in antimicrobial decision making and infection
management amongst the surgical teams is perceived to be that the priority of surgical teams is
not optimisation of antimicrobial decision making, rather it is infection avoidance (Table 5,
Q26 –Q27). In Norway, representing the most egalitarian culture in this study, though antimi-
crobial use in surgery is a recognised problem, through the hospital administration, efforts are
made to standardise clinical care across the specialties, including areas considered to be a pri-
ority for the organisation such as antimicrobial prescribing (Table 5, Q28). The overall impres-
sion of the Norwegian healthcare system is one where hierarchies do not exist in the same way
that they exist in the other healthcare systems in this study. For example, visual hierarchies are
flattened by the fact that all hospital staff from the managers and hospital chiefs to the cleaners
are required to wear the same white uniform when in clinical areas.
In England, one hospital’s solution to engaging with surgeons is through multidisciplinary
collaboration and inclusion of surgeons in the ASP initiatives. The surgeons, it is believed, will
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be more receptive to the ASP message, if it is delivered to them by a peer, i.e. someone they
consider to be from their own discipline (Table 5, Q29).
A case study of success in implementing ASP in India. In India one hospital stood out
as a case study of positive deviance and success in implementing ASP. The process of develop-
ing ASP at Hospital N, as recounted by study participants, is summarised in Fig 2. Hospital N
is a tertiary referral care charitable not-for profit organisation founded in 1997 in the state of
Kerala. The key features of this ASP are listed in Table 6. Realising that national programmes
were not implementable locally due to lack of contextual insight, the staff at the hospital
decided to tackle the issue at state level. By approaching the Ministry of Health in the state and
the medical colleges, they were able through consensus to develop a state-wide antimicrobial
prescribing policy and an education and training programme for undergraduate medical train-
ees. Organisational champion and leadership, together with team resilience resulted in suc-
cessful implementation of an ASP, in country that remains hierarchical and lacks national ASP
policies.
Discussion
This study set out to investigate how antimicrobial stewardship is developed and implemented
in different healthcare settings and economies. The findings highlight the variation in health-
care and population needs, investment, and contextual and societal norms between these
countries. The threat of AMR and HCAI however, and the need to react to these threats is
faced by all healthcare systems, though at different levels of severity. Healthcare professionals
Fig 2. Development of the ASP at hospital N as recounted by the ASP staff.
https://doi.org/10.1371/journal.pone.0209847.g002
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reported facing similar challenges in the design, development, and implementation of ASP
across contextually different healthcare economies and structures. Resources were considered
a limitation in development of ASP across all the healthcare economies, despite the variance in
per capita expenditure in healthcare, and healthcare workforce capacity. In India and Burkina
Faso, the infrastructure and expenditure in healthcare is underdeveloped, and the healthcare
workforce inadequate to meet the needs, whilst the demand for healthcare is highest. The lack
of infrastructure, poor regulations relating to access to antimicrobials, and the voluntary
accreditation of hospitals prohibit the standardisation of care that is reported in the other
three countries. The access to antimicrobials remains a critical challenge in India and Burkina
Faso, exposing the risk of black market and less potent antimicrobials infiltrating the supply
chains across the healthcare system. In addition, lack of regulation means that the patient and
the public have many informal routes to obtaining antimicrobials. To optimise antimicrobial
use and establish effective ASP in such settings, first there needs to be equitable access to stan-
dardised antimicrobials across the entire healthcare pathway. This raises the question of the
ethics of restricting excess antimicrobial use through ASP, in settings where inadequate access
to healthcare remains a key issue. There must be a balance between reducing excess antimicro-
bial use without impeding access to them. ASP is essentially about optimising antibiotic use,
and it is therefore critical that it should not impede access in vulnerable populations in
resource limited settings.
Resource restrictions to implement ASP apply in all countries in this study. In Norway, a
geographically broad country, with a dispersed population in rural areas, access to microbio-
logical laboratories [9,42] has already been reported as a limiting factor in implementing ASP.
Furthermore, as reported in this study in the larger hospitals infectious diseases and IP&C
posts remain vacant. India faces the same problem, in that infectious diseases is not a recog-
nized specialty and therefore there is a gap in specialism and expertise, which is reflected in the
strains on ASP. In England and France, the healthcare expenditure and investment by the gov-
ernment is accompanied by externally driven targets and performance measures which can
put a strain on diminishing resources. The case study from India, provides learning for other
Table 6. Key components of the ASP at hospital N.
Components of Stewardship Programme Key functions Components
A hospital wide antimicrobial policy and antibiogram
smartphone application
Policy accessible online
App on smartphones
The key tools of ASP implemented hospital
wide
There is a mechanism for escalating
recommendations through the hierarchy
Key recognised ASP activities adopted as
social norms
The physical environment adapted to
accommodate ASP e.g. electronic records
Reserved antimicrobial list– 13 antibiotics and
antifungals on the list
Pharmacist review every patient on these agents, they feedback
to the prescribers recommendations for review or de-
escalation. This information is discussed daily in Stewardship
Committee
Antimicrobial recommendation form Completed by pharmacists reviewing the patients on
antimicrobials with a recommendation to the medical team
and placed in patient notes
Electronic health records
(Developed in-house)
Supports the team in identifying patients on the reserved
antibiotics and to produce consumption reports
Interdisciplinary Antimicrobial Stewardship
Committee—including surgeons, pharmacists, and
Infection Prevention and Control (IP&C)
To meet daily to review and discuss patients
Any difficult cases referred to the medical microbiologist and
medical superintendent by the pharmacists
The social environment supports a collectivist
approach with values placed on
interdisciplinary collaboration
Surgical surveillance Surveillance of surgical site infection and the introduction of a
Standard Operating Procedure for IP&C and antibiotic use in
cardiothoracic surgery
Value placed on interdisciplinary
collaboration
Organisational leadership The programme driven by the medical superintendent ensures
continuity, acceptance, and leadership
Leadership support helps ensure desired ASP
activities are entrenched as social norms over
time
https://doi.org/10.1371/journal.pone.0209847.t006
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settings whereby locally led ASP initiatives that use interdisciplinary approach can overcome
some of the resource limitations.
Policies and guidelines, the bedrock of ASP, are not universally implemented, and where
they are implemented the value attributed to them varies. In Burkina Faso and India, where
guidelines are much needed, the national guidelines that were implemented were not fit for
purpose or context. In England and France, the two countries with the longest established
ASP, the stewardship agenda has moved beyond policy and guideline provision. It is almost as
if these interventions have been saturated. The ASP teams and the Department of Health and
national bodies are striving to convince their clinical peers in the hospital setting to adhere to
the guidelines, and to convince them of the necessity to comply with policy recommendations.
In India and Burkina Faso, the overwhelming reliance on the state endorsement has meant
that polices and guidelines are likely to be adhered to if they are ratified and endorsed by the
government or come with a punitive measure. In countries with little government led ASP,
there is a sense that only the government can incentivise and mobilise ASP efforts. This expec-
tation in LMICs for the government to ‘solve’ the issue of inappropriate antimicrobial use is in
contrast with the perception in England that government involvement may have unintended
consequences for local ASP. Arguably the level and extent of state or government input into
ASP can alter the culture of practice locally in hospitals, by shifting priorities, and over time
influencing values and norms. The extent of the unintended consequences of central govern-
ment involvement (for example the CQUIN targets in the England) in ASP have not been fully
investigated. Whilst a degree of state (top down) reinforcement and support is essential, e.g. to
ensure an adequate healthcare service accessible by all, too much intervention and micro-man-
agement can have negative and disruptive effects.
This study found that despite the expectation of multidisciplinary collaboration in ASP
from WHO and other international bodies, it is only still practiced in a limited number of
countries. In the context of this work, across India, France, and Norway doctors remain the
sole profession involved in ASP efforts. The reasons for this are manifold. The entrenched
hierarchies within the medical profession [5] that impact antimicrobial prescribing has been
described as part of previous research. However, it was interesting to find that the key study
site in these three countries exhibited a similar culture to one another, and different from
other hospitals in their own countries. This may be due to these sites being national centres of
excellence with a reputation for innovation and leading the ASP agenda. Their success is indic-
ative that with the right leadership and drive, cultural norms can be challenged and changed
over time e.g. the cultural norm of the medical profession leading quality improvement inter-
ventions, such as ASP. This is more likely to be achieved in organisations that exhibit a more
collectivist approach to team work and decision making as exemplified in the case study from
India. Against a highly hierarchical culture, with very limited resources in the healthcare sys-
tem, an increasing threat of AMR, and little government input, one hospital in India has man-
aged to establish and sustain an interdisciplinary ASP. In part this was achieved through
dedicated leadership championing the cause of ASP, and a recognition that the wider health-
care workforce including pharmacists can make a valuable contribution to clinical decision
making and patient care. This example of positive deviance carries a powerful message that
with the right leadership and interdisciplinary approach organisational cultures can be differ-
ent to the national culture.
This study reports that surgery specialties remain universally difficult to engage with
regarding ASP. The lack of adherence to ASP principles by the surgical teams also affects the
medical care of the patients. Historically ASP efforts have mainly targeted medical specialties
[17]. This is a critical oversight, and optimising antimicrobial prescribing before, during, and
after surgery should be a central tenet of tackling AMR [43]. Most of the research in ASP in
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surgery is focused on antibiotic prophylaxis, and prevention of surgical site infections [17]. It
is imperative however to engage more with surgical teams and try and address antimicrobial
prescribing more comprehensively along the entire surgical pathway. It has previously been
reported[5,11,44] that peer endorsement is an important factor in the uptake of sustainable
interventions in healthcare. ASP efforts place expectations on autonomous clinicians, includ-
ing surgeons to change their behaviours from what to them is a norm within their specialties
and areas of practice. Often the expectation yields no direct benefit to the patient at hand but is
in view of a greater good of averting the emergence of AMR and preventing HCAI. To this
end, busy, pressurized surgeons working with limited resources may not immediately see the
merits of ASP or prioritise related behaviours. The use of local champions and organisational
leaders are important determinants in shifting antimicrobial prescribing behaviours, social
norms and values over time.
Potential opportunities to affect change
The key learning from the findings in this paper are focused on workforce development, iden-
tifying key champions to drive stewardship locally and to engage with governments and policy
makers to ensure effective support for and scale up of interventions. Research on the imple-
mentation of ASP from low resource settings remains critical. By focusing within LMICs and
addressing these questions in the least resourced settings, we will maximise the opportunities
for bi-directional learning and the potential for scale up to any resource setting. There is a
much wider workforce, including pharmacists and nurses, within healthcare that can take for-
ward stewardship interventions in different settings.
Limitations
There are several limitations to the methods, and interpretation of this study. First and fore-
most, In India, France and Norway access to the pool of potential participants was gained via
key informants who were national leaders in ASP in their own countries. This may have intro-
duced selection bias. The fact that they were identified by the key informants was intentional
as the aim was to include individuals who had a role in ASP. There may have been bias in the
participants feeling obliged, coerced, or under undue influence to participate due to the key
informants having invited them. Having spent time in each of the lead institutions however,
and observing how the teams operate, coercion is not a plausible bias in this study. One of the
most advanced examples of interdisciplinary teamwork in this study is from India, a country
historically considered to be extremely patriarchal and hierarchical. Another cause for selec-
tion bias and limitation in this study was language. The need to speak English (France in Bur-
kina Faso) may have been a selection bias for the participants. In Norway and India, all
university graduates are fluent in English, therefore language was not a bias for selection.
Conclusion
At the macro level government and state infrastructures determine ASP. There is a recognised
need for legislation and investment in resources to support ASP locally, however too much
government involvement can lead to disruptions in ASP and redirection of limited resources.
A culture of hierarchies dominates the effectiveness and reach of ASP, with professional
boundaries limiting the involvement of nursing and pharmacy staff and doctors remain the
key stakeholders. ASP champions and local leadership can be used to overcome hierarchical
and rigid national and organisational cultures. There are opportunities for shared learning
from the interdisciplinary model adopted by key study hospital in India, which could break
through entrenched hierarchies. Across all the countries in this study the surgical specialties
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were identified as being the least likely specialty in acute care to adhere to ASP. To tackle
AMR, the surgical specialties in secondary care need to be included in ASP initiatives. It is crit-
ical to develop contextually driven ASP targeting the surgical pathway in different resource set-
tings. There needs to be a complete and transparent, shared understanding of the principles of
optimised antimicrobial prescribing across the entire healthcare work force in acute care,
including across surgical teams.
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